Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar 4;57(3):2004451.
doi: 10.1183/13993003.04451-2020. Print 2021 Mar.

Asthma and COVID-19: do we finally have answers?

Katrien Eger  1 , Elisabeth H Bel  2
Affiliations
Editorial

Asthma and COVID-19: do we finally have answers?

Katrien Eger et al. Eur Respir J. .

Abstract

Large-scale studies confirm previous findings about a slightly increased incidence of COVID-19, but not of severe COVID-19, in asthma patients. Still, no definitive conclusions can be drawn since many bias factors have not been taken into account. https://bit.ly/34FRfmT

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: K. Eger has nothing to disclose. Conflict of interest: E.H. Bel reports grants and personal fees from AstraZeneca, GSK, Novartis and Teva, personal fees from Sanofi/Regeneron, Sterna and Chiesi, outside the submitted work.

Figures

FIGURE 1
FIGURE 1
Factors that may influence reported incidences of (severe) coronavirus disease 2019 (COVID-19) in asthma patients. The reported incidences of (severe) COVID-19 cases among asthma patients are not determined by patient-related factors alone. Also, local factors and the applied methodologies can play an important role. ACE2: angiotensin converting enzyme 2; ICS: inhaled corticosteroids; OCS: oral corticosteroids.
See this image and copyright information in PMC

Comment on

References

    1. World Health Organization . Weekly Epidemiological Update. www.who.int/publications/m/item/weekly-epidemiological-update---1-decemb... Date last updated: 1 Dec 2020. Date last accessed: 3 Dec 2020.
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242. doi:10.1001/jama.2020.2648 - DOI - PubMed
    1. Guan W-J, Liang W-H, Zhao Y, et al. . Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55: 2000547. doi:10.1183/13993003.00547-2020 - DOI - PMC - PubMed
    1. Garg S, Kim L, Whitaker M, et al. . Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 458–464. doi:10.15585/mmwr.mm6915e3 - DOI - PMC - PubMed
    1. Choi H-G, Wee JH, Kim SY, et al. . Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control & Prevention. Allergy 2020; in press [10.1111/all.14675]. - DOI - PMC - PubMed